Shareholders of Icos ( ICOS) voted Thursday to accept a $34-a-share buyout offer from Eli Lilly ( LLY).

The vote enables Lilly to take full control of the impotence drug Cialis, which Icos developed and whose profits were shared via a marketing agreement. The $2.3 billion acquisition is expected to close Jan. 29.

Icos said 85% of its shares outstanding voted on the proposal, and that 77% of the votes supported the deal.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says